| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.98B | 83.85B | 80.26B | 85.75B | 72.30B | 55.95B |
| Gross Profit | 32.70B | 31.87B | 27.71B | 27.15B | 24.69B | 19.22B |
| EBITDA | 21.92B | 22.40B | 17.81B | 17.59B | 16.00B | 12.00B |
| Net Income | 13.85B | 14.08B | 10.92B | 10.55B | 9.68B | 7.13B |
Balance Sheet | ||||||
| Total Assets | 124.23B | 130.59B | 118.17B | 107.27B | 101.19B | 85.11B |
| Cash, Cash Equivalents and Short-Term Investments | 48.74B | 52.15B | 38.22B | 32.66B | 31.10B | 30.59B |
| Total Debt | 1.12B | 1.23B | 1.32B | 1.14B | 1.12B | 834.37M |
| Total Liabilities | 21.43B | 24.47B | 25.46B | 22.90B | 22.48B | 15.63B |
| Stockholders Equity | 102.80B | 106.12B | 92.71B | 84.36B | 78.71B | 69.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.00B | 10.13B | 7.37B | 4.70B | 7.33B |
| Operating Cash Flow | 0.00 | 19.20B | 12.44B | 13.46B | 7.42B | 8.68B |
| Investing Cash Flow | 0.00 | -3.59B | -1.12B | -6.71B | -4.69B | -3.91B |
| Financing Cash Flow | 0.00 | -3.53B | -6.27B | -7.55B | -3.79B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥347.02B | 24.12 | 13.36% | 1.87% | 1.18% | 4.57% | |
76 Outperform | ¥520.90B | 20.36 | 6.52% | 1.82% | 3.25% | -11.31% | |
75 Outperform | ¥190.08B | 13.84 | ― | 3.50% | 3.85% | -1.53% | |
74 Outperform | ¥333.27B | 12.62 | 5.47% | 3.41% | 2.60% | 9.50% | |
65 Neutral | ¥437.69B | 12.96 | 8.14% | 2.61% | -1.45% | ― | |
63 Neutral | ¥314.86B | 12.71 | 8.86% | 2.65% | -0.04% | 3.15% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |